Shuttle Pharmaceuticals Holdings Inc Sustainability Reports
Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies to improve the effectiveness of radiation therapy in cancer treatments. It designs radiation sensitizers to increase cancer cure rates and prolong patient survival while minimizing the side effects of radiation.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2022 to 2024